Lydia Lim 33rd Lorne Cancer Conference 2021

Abstracts this author is presenting:

• Inhibiting PRMT5: A novel therapeutic strategy for MAPK inhibitor-resistant melanoma  — Morning Tea and E-Poster Presentations